IONS
#905
Ionis Pharmaceuticals, Inc. - Common Stock
61.1 2 USD
+0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+2.07%
Changement Mensuel
+16.07%
Evolution sur 6 mois
-24.00%
Changement Annuel
-15.26%
Clôture Précédente
59.8 8
Open
60.8 2
Low
60.7 7
High
61.1 7
Volume
358
Financials
- Market Capitalization 10.16 B
- Employee 1 402
- Founded 1989
- CEO Brett P. Monia Ph.D.
- Website www.ionis.com
- Headquarter California, United States
- FIGI BBG000JH6683
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-68.35
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 861 |  KRYS Krystal Biotech, Inc. - Common Stock | 365.81 USD | +0.54% | +1.10% | +14.07% | +95.48% | 10.83 B USD | ||
| 872 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 207.06 USD | +2.09% | -0.62% | -3.92% | +59.03% | 10.85 B USD | ||
| 907 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.44 USD | +0.20% | +0.88% | +7.51% | +100.38% | 10.11 B USD | ||
| 908 |  CYTK Cytokinetics, Incorporated - Common Stock | 70.96 USD | -0.62% | -10.44% | -7.47% | +22.13% | 9.87 B USD |